title: Treatment considerations with aldosterone receptor antagonists.
authors.affiliation: Division of Nephrology, Department of Medicine and Pharmacology, Clinical Pharmacology and Hypertension, Virginia Commonwealth University Health System, Richmond, VA 23298-0160, USA. dsica@airwaves.org
authors.forename: Domenic A
authors.initials: DA
authors.lastname: Sica
authors.forename: John M
authors.initials: JM
authors.lastname: Flack
mesh_terms: D004305:Dose-Response Relationship, Drug; D000077545:Eplerenone; D006706:Homeostasis; D006801:Humans; D006947:Hyperkalemia / Q000517:prevention & control; D006973:Hypertension / Q000188:drug therapy*; D007668:Kidney / Q000502:physiology; D008274:Magnesium / Q000378:metabolism; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone; D008274:Magnesium